Search

Your search keyword '"Luc Biedermann"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Luc Biedermann" Remove constraint Author: "Luc Biedermann" Journal gastroenterology Remove constraint Journal: gastroenterology
48 results on '"Luc Biedermann"'

Search Results

1. A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus

2. Defer No Time, Delays Have Dangerous Ends (William Shakespeare)

3. 881: BUDESONIDE ORODISPERSIBLE TABLETS MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 96-WEEKS OPEN-LABEL EXTENSION PHASE FOLLOWING THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

4. Sa1182: LONGITUDINAL FOLLOW-UP OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR POTENTIAL TO PROGRESS TO EOE: A CLINICAL, HISTOLOGICAL AND MOLECULAR MULTI-CENTER ANALYSIS

9. Mo1129 THE IMPACT OF A SNP-DOSE-RESPONSE-EFFECT ON COURSE OF INFLAMMATORY BOWEL DISEASE: A NUMERICAL ANALYSIS OF SNP DISTRIBUTION WITHIN THE SWISS IBD COHORT STUDY

10. 226 FOOD-INDUCED IMMEDIATE RESPONSE IN THE ESOPHAGUS – A BURNING FIRE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

11. Mo1826 THE IMPACT OF TOTAL COLECTOMY ON THE COURSE OF EXTRAINTESTINAL MANIFESTATIONS IN SWISS IBD COHORT STUDY PATIENTS

12. Mo1185 ENDOSCOPY DETECTS HISTOLOGIC REMISSION WITH VERY GOOD DIAGNOSTIC ACCURACY IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS

13. Mo1129 – Efficacy of Budesonide Orodispersible Tablets for Induction of Remission in Patients with Active Eosinophilic Esophagitis: Results from the 6-Weeks Open-Label Treatment Phase of Eos-2 Trial

14. Mo1145 – Eosinophilic Esophagitis is Associated with a Higher Education Level Compared to the Swiss General Population

15. Su1873 – Remission to Vedolizumab is Not Higher in TNF-Naive Compared to TNF-Pretreated Patients with Crohn’s Disease

16. Mo1146 – Clinical Manifestation, Course of Disease and Evaluation of Treatment Response Including Vedolizumab in a Large Swiss Case Series of Eosinophilic Gastroenteritis Patients

17. Sa1824 – Obesity is Frequent in Inflammatory Disease Patients and Associated with Higher Disease Activity in Crohn’s Disease, But Not in Ulcerative Colitis

18. 951a – Budesonide Orodispersible Tablets are Highly Effective to Maintain Clinico-Histological Remission in Adult Patients with Eosinophilic Esophagitis: Results from the 48-Weeks, Double-Blind, Placebo-Controlled, Pivotal Eos-2 Trial

19. 358 – Close Follow-Up is Associated with Fewer Stricture Formation and Results in Earlier Detection of Histological Relapse in the Long-Term Management of Eosinophilic Esophagitis

20. Frequency and Type of Drug-Related Side Effects Necessitating Drug Cessation in the Swiss Inflammatory Bowel Disease Cohort

22. Mo1866 - Immunosuppressive and Anti-TNF Treatment is Associated with a Lower Risk of Migration from B1-to-B3-Stage in Crohn's Disease: 10-Year-Follow-Up Data from the Swiss IBD Cohort Study

23. 326 - Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-Year-Follow-Up Data from the Swiss IBD Cohort Study

24. Mo1859 - Early Initiation of Anti-TNF is Associated with Favorable Long-Term Outcome in Crohn's Disease: 10-Year-Follow-Up Data from the Swiss IBD Cohort Study

25. Sa1144 - Treatment Preferences of Adult Eosinophilic Esophagitis Patients

26. Su1848 - Low Seroprevalence of Celiac Disease in a Large Screening Study in Unselected IBD Patients from the Swiss IBD Cohort Study

27. Su1889 - Risk of Cancer in Inflammatory Disease Patients is Associated with age and Recent use of Immunomodulators, While Biologics and Aminosalicylates are Protective Factors - A Cross-Sectional and Follow-Up Analysis of the Swiss IBD Cohort Study

28. 311 - Maintenance Treatment of Eosinophilic Esophagitis with Swallowed Topical Corticosteroids Alters Disease Course: A 5-Year Follow-Up

29. Vegetarian or Gluten-Free Diet in Patients with IBD andAssociated with Lower Psychological Well-Being and Quality of Life but no Indication of Beneficial Effects on Course of Disease

30. Risk Factors for the Development of Fistulae and Stenoses in Crohn's Disease Patients in the Swiss IBD Cohort

32. Su1822 Influence of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease

33. Su1821 Characterization of Pain in IBD Patients in the Swiss IBD Cohort Study

34. The way to a man's stomach is through his heart

35. Tu1356 Efficacy of Certolizumab Pegol in an Unselected Crohn's Disease Population: Long-Term Data of the FACTS III Survey

38. Sa1275 The Diagnostic Delay in Celiac Disease Is Significantly Increased in Women Due to Doctor's but Not Patient's Delay

39. Mo1813 Antibiotics Provoke a Dysbiosis - Isotretinoin Not

40. Tu1185 Smoking in Patients With IBD: Increasing Smoking Rates and Alarmingly Low Use of Supportive Measures to Achieve Smoking Cessation -Data From the Swiss IBD Cohort Study

41. Sa1762 T Cell Specific Loss of PTPN2 Leads to Miss-Balanced T Helper Cell Differentiation Resulting in Aggravated Intestinal Inflammation

42. Su1410 Patient Perceptions on the Impact of Coffee Consumption in Inflammatory Bowel Disease: Friend or Foe?

43. Tu1771 Smoking Cessation Alters Intestinal Microbiota: Further Insights From Quantitative Investigations on Human Fecal Samples Using FISH and qPCR

44. Mo1257 Risk Factors for Repetitive Ileocolic Resection in Crohn's Disease Patients

45. Sa1886 Bilberry Ingestion Improves Disease Activity in Mild to Moderate Ulcerative Colitis - an Open Pilot Study

46. Tu1882 FC Gamma Receptors Modulate the Inhibitory Efficacy of Infliximab in Blocking TNF-Mediated Responses in Blood and Intestine of IBD Patients

48. Smoking Cessation Leads to Profound Changes in the Composition of the Intestinal Microbiota – A Controlled Prospective Interventional Study Using Terminal Restriction Fragment Length Polymorphism and Pyrosequencing

Catalog

Books, media, physical & digital resources